SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant market attention as traders bet on a potential short squeeze amid high short interest and heavy institutional buying. The community remains focused on upcoming regulatory catalysts, global manufacturing expansion for its cell therapy platform, and the company's long-term potential to transform oncology treatment.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing intense community debate as the stock trades near 52-week lows, with investors weighing strong product growth and the Alani Nu integration against broader market concerns and margin pressures. The community is actively tracking upcoming earnings and potential institutional accumulation, while some investors interpret the recent price weakness as a short-term shakeout before a rebound.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors focus on its strong fundamental performance, including a series of profitable quarters, and the potential for a technical breakout following recent AAA-rated asset-backed securities deals. The community is actively debating the stock's significant valuation gap compared to sector peers and analyzing how its AI-driven credit model and expanding institutional partnerships could trigger a rebound as the company prepares for upcoming earnings.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing massive volume and price volatility driven by a new hedge fund report positioning the company as a key stealth supplier of optical components for AI data centers and smart glasses. The community is actively debating whether this movement signals a long-term fundamental rerating or if it represents a volatile 'buy-the-news' trap prone to rapid reversals.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is drawing significant investor attention as it rolls out an aggressive value-focused menu strategy, including items priced at three dollars or less, to combat recent traffic declines and address consumer concerns over affordability. While the community remains divided over the stock's long-term potential, ongoing discussions frequently highlight a clash between the company's defensive real estate model and persistent criticism regarding leadership direction and perceived food quality.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility driven by ongoing debates over Elevidys clinical efficacy and concerns regarding Roche's decision to initiate a new global Phase 3 trial for the therapy. While the community remains deeply polarizedwith some investors highlighting undervaluation relative to the company's approved portfolio and others raising alarms over regulatory hurdles and potential cash burnsentiment is further pressured by aggressive analyst downgrades and persistent short interest.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is seeing heightened market activity driven by positive preclinical data for its ERNA-101 ovarian cancer therapy, which showed complete tumor elimination in syngeneic models. While some members of the community are optimistic about the company's valuation relative to its pipeline and MD Anderson collaboration, others remain skeptical, pointing to the company's history of reverse splits and the inherent risks of early-stage, pre-human clinical research.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending as investors weigh strong underlying enterprise growth and AI-driven demand against significant short-term volatility and sector-wide sentiment shifts. The community remains divided, with many traders debating whether recent pullbacks represent an attractive entry point for a long-term AI infrastructure play or a deeper valuation reset for the software sector.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is rallying as investors react to its strategic acquisition of Mirantis, which bolsters its AI cloud capabilities and enterprise reach ahead of impending earnings. The community is actively debating the significance of this full-stack shift in securing large-scale hyperscaler contracts and driving long-term value.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is trending as it pre-announced better-than-expected revenue guidance and signaled the sunsetting of its ironSource Ads Network, fueling community speculation about a potential strategic turnaround. Investors are actively debating the stock's future, weighing these positive business updates against the significant short interest and lingering skepticism following previous management and growth struggles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Teradyne Stock Trades at a Premium: Should You Buy Now or Wait?

TER benefits from booming AI demand, driving strong growth across segments and reinforcing momentum as investors eye continued upside potential.


Should You Buy, Sell or Hold AMAT Stock at a P/S Valuation of 9.39X?

Applied Materials trades at a premium P/S valuation as AI-driven demand in DRAM, logic and advanced packaging boosts growth across its wafer fab portfolio.

KLA (NASDAQ:KLAC) Price Target Raised to $1,970.00

Citic Securities increased their price objective on KLA from $1,350.00 to $1,970.00 in a report on Wednesday...

ROK Beats Q2 Earnings Estimates on Higher Volume, Hikes FY26 View

Rockwell Automation tops Q2 earnings estimates with strong volume, margin gains and organic growth, prompting a higher FY26 view amid broadening demand. 

KLA (KLAC) International Revenue in Focus: Trends and Expectations

Examine the evolution of KLA's (KLAC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

KLA Corporation $KLAC Holdings Decreased by Robocap Asset Management Ltd

Robocap Asset Management Ltd reduced its stake in shares of KLA Corporation (NASDAQ:KLAC - Free Report) by 53.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,204 shares of the sem...

Horizon Investments LLC Has $8.98 Million Stock Position in KLA Corporation $KLAC

Horizon Investments LLC lowered its position in shares of KLA Corporation (NASDAQ:KLAC - Free Report) by 32.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,394 shares of the semiconductor company's stock after selling 3,587 shares...

PFA Pension Forsikringsaktieselskab Buys New Shares in KLA Corporation $KLAC

PFA Pension Forsikringsaktieselskab bought a new stake in shares of KLA Corporation (NASDAQ:KLAC - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities...

KLA (NASDAQ:KLAC) Shares Unloaded Rep. Lizzie Fletcher

Representative Lizzie Fletcher (Democratic-Texas) recently sold shares of KLA Corporation (NASDAQ:KLAC). In a filing disclosed on May 01st, the Representative disclosed that they had sold between $1,001 and $15,000 in KLA stock on April 8th. The trade occurred in the Representative's "FILER BROKERAG...

KLA (NASDAQ:KLAC) Price Target Raised to $2,000.00

Berenberg Bank boosted their price target on KLA from $1,770.00 to $2,000.00 and gave the stock a "buy" rating in a report on Thursday...

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Current Price	$1,816.29
Prev Close	$1,732.90
Open	$1,784.69
Dividend Yield	0.75%
50-Day Moving Average	$1,605.98
Beta	1.94
Avg. Volume	907,140.76
PE Ratio	51.35

52-Week High	$1,939.36
52-Week Low	$692.80
Market Capitalization	$226.36B
EPS (Annual)	$30.37
Price to Book	40.72
Revenue Per Employee	$799,256.32

KLAC
KLA Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KLAC News

KLACKLA Corp.